Bufexamac

This classification denotes a non-steroidal anti-inflammatory agent with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4T3C38J78L, chemically known as benzeneacetamide, 4-butoxy-n-hydroxy- (9ci) but generally known as bufexamac, which bears US NIH Compound Identifier 2466. European Medicines Agency schedules Bufexamac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05961MIG. World Health Organization schedules bufexamac in its Anatomical Therapeutic Chemical (ATC) Classification. BUFEXAMAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bufexamac under HS 29280090 and SITC 51486. As of Q4 2014, BUFEXAMAC remains the US FDA Preferred Term for this commodity. SMILES: CCCCOC1=CC=C(C=C1)CC(=O)NO.